Valuation of lost productivity of adults with X-linked Hypophosphataemia and Osteogenesis imperfecta

Valuation of lost productivity of adults with X-linked Hypophosphataemia and Osteogenesis imperfecta

Bibliographic Details
Main Authors:	Cole, S, Javaid, M, Pinedo Villanueva, R
Format:	Conference item
Language:	English
Published:	Springer Nature 2023

Similar Items

Valuation of lost productivity for people with osteogenesis imperfecta: preliminary results from the RUDY cohort
by: Cole, SE, et al.
Published: (2022)

Valuation of lost productivity for individuals diagnosed with Osteogenesis imperfecta: follow-up findings from the Rudy Cohort Study in the UK
by: Cole, S, et al.
Published: (2022)

Description of hospital use by patients with osteogenesis imperfecta in the English NHS
by: Kolovos, S, et al.
Published: (2020)

Cluster analysis of patient-reported outcome measures of adults with X-linked hypophosphataemia
by: Cole, S, et al.
Published: (2022)

Hospital admissions of patients with osteogenesis imperfecta in the English NHS
by: Kolovos, S, et al.
Published: (2021)

Physical function in UK adults with osteogenesis imperfecta: a cross-sectional analysis of the RUDY study
by: Orlando, G, et al.
Published: (2020)

Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia
by: Forestier-Zhang, L, et al.
Published: (2016)

Calcitonin in osteogenesis imperfecta.
by: Smith, R, et al.
Published: (1973)

Patient-reported outcomes of X-linked hypophosphataemia registry participants in the UK
by: Cole, S, et al.
Published: (2021)

Conceptualization and validation of a health economic model for osteogenesis imperfecta
by: Edmonds, T, et al.
Published: (2024)

Subgroups of adults with X-linked hypophosphataemia: cluster analysis of patient-reported outcome measures of participants in a UK rare diseases cohort
by: Cole, S, et al.
Published: (2021)

Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK
by: Cole, S, et al.
Published: (2023)

Cardiovascular abnormalities in osteogenesis imperfecta.
by: White, N, et al.
Published: (1983)

Quality of life in adults with X-linked hypophosphataemia (XLH): Preservation of emotional well-being despite significant limitations in physical domains
by: Pinedo-Villanueva, R, et al.
Published: (2017)

A cross-sectional study of patient-reported outcomes of individuals with X-linked hypophosphataemia within the UK
by: Cole, S, et al.
Published: (2021)

X-linked hypophosphataemia: burden of disease using United Kingdom primary care data
by: Javaid, M, et al.
Published: (2018)

A longitudinal study of patient-reported outcomes of RUDY registry participants with X-linked hypophosphataemia in the UK
by: Cole, S, et al.
Published: (2021)

The ROSI study (risedronate in adults with osteogenesis imperfecta type 1)
by: Duncan, E, et al.
Published: (2005)

Estimating the benefits of reduced fracture incidence for patients living with osteogenesis imperfecta and for healthcare payers
by: Edmonds, T, et al.
Published: (2024)

Osteogenesis imperfecta is linked to both type I collagen structural genes.
by: Sykes, B, et al.
Published: (1986)

Prevalence and mortality of individuals with X-linked hypophosphataemia: a United Kingdom real world data analysis
by: Hawley, S, et al.
Published: (2019)

Estimating the burden of osteogenesis imperfecta on patients and healthcare payers: a health economic modelling study
by: Edmonds, T, et al.
Published: (2024)

X-linked hypophosphataemia: prevalence and mortality rate within the United Kingdom Clinical Practice Research Datalink
by: Hawley, S, et al.
Published: (2019)

Molecular and Mesoscale Mechanisms of Osteogenesis Imperfecta Disease
by: Uzel, Sebastien Guy Marcel, et al.
Published: (2011)

Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: A UK parallel cohort study using CPRD
by: Hawley, S, et al.
Published: (2020)

Molecular and Mesoscale Mechanisms of Osteogenesis Imperfecta Disease in Collagen Fibrils
by: Gautieri, Alfonso, et al.
Published: (2015)

Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
by: Jones, G, et al.
Published: (2014)

CONSISTENT LINKAGE OF DOMINANTLY INHERITED OSTEOGENESIS IMPERFECTA TO COLLAGEN-1 GENES
by: Sykes, B, et al.
Published: (1988)

Structure–mechanics relationships of collagen fibrils in the osteogenesis imperfecta mouse model
by: Andriotis, O. G., et al.
Published: (2016)

The ROSI study (Risedronate in adults with osteogenesis imperfecta type 1): Improved BMD but high fracture rate persists.
by: Bradbury, L, et al.
Published: (2006)

Mutations of the PEX regulatory and C-terminal regions cause X-linked hypophosphataemia.
by: Dixon, P, et al.
Published: (1997)

Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.
by: Bradbury, L, et al.
Published: (2012)

TYPE-I COLLAGEN STRUCTURAL GENES IN OSTEOGENESIS IMPERFECTA AND OTHER HERITABLE DISORDERS OF CONNECTIVE-TISSUE
by: Wordsworth, B, et al.
Published: (1987)

Lethal osteogenesis imperfecta and a collagen gene deletion. Length polymorphism provides an alternative explanation.
by: Sykes, B, et al.
Published: (1985)

Prevalence of cardiovascular disease events and determinants in patients with x-linked hypophosphatemia
by: Maronga, C, et al.
Published: (2023)

Prevalence and risk factors of hypertension among patients with X-linked hypophosphatemia
by: Maronga, C, et al.
Published: (2023)

Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties.
by: Vanleene, M, et al.
Published: (2011)

Elucidation of proteostasis defects caused by osteogenesis imperfecta mutations in the collagen-α2(I) C-propeptide domain
by: Doan, Ngoc-Duc, et al.
Published: (2021)

Elucidation of proteostasis defects caused by osteogenesis imperfecta mutations in the collagen-α2(I) C-propeptide domain
by: Doan, Ngoc Duc, et al.
Published: (2022)

A literature review of the healthcare resource use and productivity burden of X-linked hypophosphatemia
by: Pinedo Villanueva, R, et al.
Published: (2023)